Friday, October 4, 2019

F.D.A. Approves New H.I.V.-Prevention Drug, but Not for Women by APOORVA MANDAVILLI


By APOORVA MANDAVILLI

Citing a lack of evidence, the agency will require Gilead to conduct further trials in women.

Published: October 3, 2019 at 08:00PM

from NYT Health https://ift.tt/31OwHFd
via IFTTT



from WordPress https://ift.tt/2IniO9i
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)